Viyash Scientific Ltd Initiating Coverage Research Report | Sushil Finance
Enquire Now
×

Enquire Now

Research / Initiating Coverage / Viyash Scientific Ltd

Initiating Coverage

Viyash Scientific Ltd

CMP: Rs.232
Recommendation: BUY
Target: Rs.314
Report Date:

INDUSTRY DYNAMICS FAVORABLE FOR THE GROWTH

The most potent catalyst for the Indian CDMO sector is the implementation of the United States BIOSECURE Act. This legislation aims to restrict US entities from utilizing federal funds to procure biotechnology equipment or services from specific foreign adversarial companies, citing national security concerns. The Act explicitly targets prominent Chinese CDMOs and genomics firms, including WuXi AppTec, WuXi Biologics, BGI, MGI, and Complete Genomics. China currently commands a 30% to 35% share of the global API and CDMO market, representing roughly US$ 60 billion to US$ 75 billion in annual revenue. So even a fraction shift in the market share to India, should benefit the Indian companies.

Global pharmaceutical innovators and large generic conglomerates are under immense pressure to decouple their supply chains from Chinese manufacturers due to geopolitical tensions and environmental disruptions. By offering a fully localized, USFDA-compliant manufacturing ecosystem rooted in India, Viyash secures long-term, high-volume contracts by guaranteeing supply security to its partners

BACKWARD INTEGRATION AND PRODUCT AND GEOGRAPHIC EXPANSION TO DRIVE GROWTH

While near-term growth is supported by existing capacity, backward integration and volume optimization, the true structural inflection in Viyash’s earnings profile is back-ended and tied to its complex R&D engine. The company has deliberately pivoted away from commoditized, high-volume generic APIs toward high-barrier, complex therapeutic areas such as oncology and central nervous system (CNS) treatments. Developing these highly potent active pharmaceutical ingredients (HPAPIs) and cytotoxic drugs requires specialized containment infrastructure (OEB-4/5 levels) and a long gestation period, typically taking five to seven years from development to commercialization. The company has guided for a revenue of $1bn by 2032 and a $150-200 mn companion ambition for the long term with high potency API launches around 2029, while it is confident to achieve Rs.4000 cr in FY27, with improving margins due to focus on high potent APIs.

OUTLOOK AND VALUATION

We expect the company’s topline to grow at a CAGR of ~15% to Rs. 5,138 cr in FY26-29E. On conservative basis, we have expected EBITDA margin to remain at healthy level, 19%. Hence, with an expected PAT margin of 9% in FY29E, we expect the PAT and EPS to be at Rs. 466 cr and Rs. 10.7 respectively. We have assigned a P/E multiple of 30x to arrive at a price target of Rs. 314 which provides an upside of ~35% within 18 to 24 months from the current market price of Rs.232.



Checkout More Research
Initiating Coverage
Results Update
Target Update

About the company

Established in 1982 by Mr. Sushil N. Shah as a proprietary concern, SUSHIL FINANCE, over a period of time, has emerged as one of India’s leading Financial Services.... Read More
Sushil Connect App for Stock Recommendations QR Code Savashare Mobile Trading App for Stock Trading QR Code


Prevent Unauthorized Transactions in your Demat Account
- Update your Mobile Number with your Depository Participant.
- Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same  day issued in the interest of investors.
Registered Office : Sushil Financial Services Private Limited., 12, Homji Street Fort Mumbai-400 001 • Tel. No. +91-22-40936000 • Fax No. +91-22-22665758 • Email: info@sushilfinance.com

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. Receive alerts on your Registered Mobile number for all debit and other important transactions in your demat account directly from CDSL on the same day. Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.

Sushil Financial Services Private Limited - CIN No. U67120MH1991PTC063438- Member : BSE/ NSE. SEBI Registration No. - INZ000165135.. Depository Participant (CDSL) SEBI Registration No.- IN-DP-504-2020. Research Analyst SEBI Registration No.- INH000000867. BSE Enlistment no for RA : 5051. IPO Distributor. AMFI Registered Mutual Fund Distributor ARN No. 77875 Registered Since : 04-Jan-2010 Valid till : 03-Jan-2027

Compliance Officer Details: Name: Mr. Suresh Nemani, Email id: suresh.nemani@sushilfinance.com, Contact No: 022-40935000. In case of any grievances, please write to us on compliance@sushilfinance.com

SEBI presents Samajh Se Investing Simple:
1. Understand Before You Invest 2. Choose Regulated Investment Products 3. Start Early, Stay Invested 4. Beware of Investment Frauds’

Disclaimer :

For Research Analyst: Registration granted by SEBI, Enlistment as RA with Exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Mutual fund investments are subject to market risks, read all scheme related documents carefully.

Attention Investors:
• (PDF document) Short Sell Reporting (PDF) • || • Precautions for clients dealing in options • || • Investor Charter : Annexure A – Stock Broker | Annexure A – Research Analyst (RA) | Annexure A – DP | Annexure B - DP • || • Advisory for KYC updation • || • Advisory for Investors • || • Investor Awareness regarding the revised guidelines on Margin Collection • || • Link your Aadhar number with us here. • || • IPO Subscription: " UPI Mechanism is Compulsory for Retail Investors. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." • || • Prevent Unauthorized Transactions in your Demat Account remains in investor's account." • || • Prevent Unauthorized Transactions in your Demat Account- Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile number for all debit and other important transactions in your demat account directly from CDSL on the same day. “ISSUED IN THE INTEREST OF INVESTORS” "Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day . Issued in the interest of Investors."

Attention :
We have identified 2 Fake Facebook profiles & 1 Twitter(X) Account misusing our brand name Sushil Finance. The profile is misleading and may potentially harm our brand’s reputation and misguide our clients. Fake Facebook Profile Links are : https://www.facebook.com/profile.php?id=100066549487894 | https://www.facebook.com/profile.php?id=100076277230334

Request you all to report this profile immediately by clicking on the above link > Tap on the 3 dots > Select Report Profile > Choose Fake Profile >Then choose A Business > Then search our Sushil Finance Official Page > Submit. Our official Facebook channel is: https://www.facebook.com/SushilFinanceCompanies

Fake Twitter(X) Account Link: https://x.com/SushilefinanceC

Request you all to report this account immediately by clicking on the above link > Tap on the account Name > More with 3 dots > Select Report > Choose Scam or Fraud >Then choose Impersonation >This account is impersonating our brand Sushil Finance. Our official account is: https://x.com/sushilfinance


© 2025 Sushil Finance. All rights reserved.